Crook J - Search Results

1

Median 5 year follow-up of 125iodine brachytherapy as monotherapy in men aged<or=55 years with favorable prostate cancer.

Gómez-Iturriaga Piña A, Crook J, Borg J, Lockwood G, Fleshner N. Gómez-Iturriaga Piña A, et al. Among authors: crook j. Urology. 2010 Jun;75(6):1412-6. doi: 10.1016/j.urology.2009.04.101. Epub 2009 Dec 29. Urology. 2010. PMID: 20035986

2

Brachytherapy of neck metastases.

Choo R, Grimard L, Esche B, Crook J, Genest P, Odell P. Choo R, et al. Among authors: crook j. J Otolaryngol. 1993 Feb;22(1):54-7. J Otolaryngol. 1993. PMID: 7680385

3

Clinical relevance of trans-rectal ultrasound, biopsy, and serum prostate-specific antigen following external beam radiotherapy for carcinoma of the prostate.

Crook J, Robertson S, Collin G, Zaleski V, Esche B. Crook J, et al. Int J Radiat Oncol Biol Phys. 1993 Sep 1;27(1):31-7. doi: 10.1016/0360-3016(93)90418-u. Int J Radiat Oncol Biol Phys. 1993. PMID: 7690016

4

Routine prostate biopsies following radiotherapy for prostate cancer: results for 226 patients.

Crook JM, Perry GA, Robertson S, Esche BA. Crook JM, et al. Urology. 1995 Apr;45(4):624-31; discussion 631-2. doi: 10.1016/S0090-4295(99)80054-5. Urology. 1995. PMID: 7716843 Review.

5

Effect of pelvic radiotherapy for prostate cancer on bowel, bladder, and sexual function: the patient's perspective.

Crook J, Esche B, Futter N. Crook J, et al. Urology. 1996 Mar;47(3):387-94. doi: 10.1016/S0090-4295(99)80458-0. Urology. 1996. PMID: 8633407

6

Radiotherapy for localized prostate carcinoma. The correlation of pretreatment prostate specific antigen and nadir prostate specific antigen with outcome as assessed by systematic biopsy and serum prostate specific antigen.

Crook JM, Bahadur YA, Bociek RG, Perry GA, Robertson SJ, Esche BA. Crook JM, et al. Cancer. 1997 Jan 15;79(2):328-36. doi: 10.1002/(sici)1097-0142(19970115)79:2<328::aid-cncr16>3.0.co;2-2. Cancer. 1997. PMID: 9010106

7

Serum prostate-specific antigen profile following radiotherapy for prostate cancer: implications for patterns of failure and definition of cure.

Crook JM, Choan E, Perry GA, Robertson S, Esche BA. Crook JM, et al. Urology. 1998 Apr;51(4):566-72. doi: 10.1016/s0090-4295(97)00650-x. Urology. 1998. PMID: 9586608

8

Percent free prostate-specific antigen after radiotherapy for prostate cancer.

Crook JM, Bunting PS. Crook JM, et al. Urology. 1998 Jul;52(1):100-5. doi: 10.1016/s0090-4295(98)00119-8. Urology. 1998. PMID: 9671878

9

Intermittent androgen suppression in the management of prostate cancer.

Crook JM, Szumacher E, Malone S, Huan S, Segal R. Crook JM, et al. Urology. 1999 Mar;53(3):530-4. doi: 10.1016/s0090-4295(98)00547-0. Urology. 1999. PMID: 10096379 Clinical Trial.

10

Postradiotherapy prostate biopsies: what do they really mean? Results for 498 patients.

Crook J, Malone S, Perry G, Bahadur Y, Robertson S, Abdolell M. Crook J, et al. Int J Radiat Oncol Biol Phys. 2000 Sep 1;48(2):355-67. doi: 10.1016/s0360-3016(00)00637-4. Int J Radiat Oncol Biol Phys. 2000. PMID: 10974448

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

740 results

Search Page

Filters